194 related articles for article (PubMed ID: 6387896)
1. Immunological effects of diethylstilbestrol and estramustine phosphate.
Haukaas SA
Scand J Urol Nephrol Suppl; 1984; 83():1-32. PubMed ID: 6387896
[No Abstract] [Full Text] [Related]
2. Effect of treatment with diethylstilbestrol-polyestradiol phosphate or estramustine phosphate (estracyt) on natural killer cell activity in patients with prostatic cancer.
Kalland T; Haukaas S
Invest Urol; 1981 May; 18(8):437-9. PubMed ID: 7228576
[TBL] [Abstract][Full Text] [Related]
3. [Antithrombin III levels in patients with advanced carcinoma of the prostate treated with estrogens].
Montserrat Orri V; de Torres Mateos JA; Malet Carreras JM; Idoipe Tomás JI; Morote Robles J
Actas Urol Esp; 1985; 9(4):327-30. PubMed ID: 4050560
[No Abstract] [Full Text] [Related]
4. Estramustine phosphate vs diethylstilbestrol in the treatment of stage D prostate cancer.
Benson RC; Cummings K
Prog Clin Biol Res; 1989; 303():177-86. PubMed ID: 2674984
[No Abstract] [Full Text] [Related]
5. French multicenter study on the use of estramustine phosphate versus diethylstilbestrol.
Hauchecorne J
Prog Clin Biol Res; 1987; 243B():229-34. PubMed ID: 3309983
[No Abstract] [Full Text] [Related]
6. In vitro and in vivo effects of diethylstilbestrol and estramustine phosphate (Estracyt) on the mitogen responsiveness of human peripheral blood lymphocytes.
Haukaas S; Høisaeter PA; Kalland T
Prostate; 1982; 3(4):405-14. PubMed ID: 7122333
[TBL] [Abstract][Full Text] [Related]
7. Estramustine phosphate versus stilbestrol as primary treatment for metastatic cancer of the prostate.
Nickel CJ; Morales A
Can J Surg; 1983 Sep; 26(5):434-8. PubMed ID: 6351988
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular side effects of diethylstilbestrol, cyproterone acetate, medroxyprogesterone acetate and estramustine phosphate used for the treatment of advanced prostatic cancer: results from European Organization for Research on Treatment of Cancer trials 30761 and 30762.
de Voogt HJ; Smith PH; Pavone-Macaluso M; de Pauw M; Suciu S
J Urol; 1986 Feb; 135(2):303-7. PubMed ID: 2935644
[TBL] [Abstract][Full Text] [Related]
9. Estramustine for prostate cancer.
Med Lett Drugs Ther; 1982 Aug; 24(615):74. PubMed ID: 7099111
[No Abstract] [Full Text] [Related]
10. Immunotoxicology--1985.
Loose LD
Year Immunol; 1986; 2():365-70. PubMed ID: 3107240
[No Abstract] [Full Text] [Related]
11. A comparison of the effect of diethylstilbestrol with low dose estramustine phosphate in the treatment of advanced prostatic cancer: final analysis of a phase III trial of the European Organization for Research on Treatment of Cancer.
Smith PH; Suciu S; Robinson MR; Richards B; Bastable JR; Glashan RW; Bouffioux C; Lardennois B; Williams RE; de Pauw M
J Urol; 1986 Sep; 136(3):619-23. PubMed ID: 3525866
[TBL] [Abstract][Full Text] [Related]
12. Estramustine phosphate as primary therapy for metastatic prostate cancer. Preliminary results of the University of Wisconsin trial.
Benson RC
Urology; 1984 Jun; 23(6 Suppl):69-72. PubMed ID: 6375084
[No Abstract] [Full Text] [Related]
13. [Cellular immunity in prostatic cancer modified by Cytonal, Estrazyt and Turisteron].
Klebingat KJ; Panzig E; Lorenz G; Steinhauser I; Fiedler R
Z Urol Nephrol; 1987 Mar; 80(3):139-47. PubMed ID: 3300097
[TBL] [Abstract][Full Text] [Related]
14. Immunologic effects of estramustine phosphate.
Kalland T; Haukaas SA
Urology; 1984 Jun; 23(6 Suppl):39-45. PubMed ID: 6375078
[No Abstract] [Full Text] [Related]
15. Estramustine affects bone mineral metabolism in metastatic prostate cancer.
Citrin DL; Wallemark CB; Nadler R; Geiger C; Tuttle K; Kaplan EH; Hauck W
Cancer; 1986 Nov; 58(10):2208-13. PubMed ID: 3756769
[TBL] [Abstract][Full Text] [Related]
16. Cancer of the prostate. Treating metastasis with estramustine phosphate.
Hoeft RT; Jones AG
Am J Nurs; 1982 May; 82(5):829-30. PubMed ID: 6918193
[No Abstract] [Full Text] [Related]
17. [Treatment of advanced carcinoma of the prostate with estramustine phosphate (estracyt)].
Lancina Martín JA; Chantada Abal V; Lamas Meilan AC; González Martín M
Actas Urol Esp; 1984; 8(5):399-402. PubMed ID: 6524487
[No Abstract] [Full Text] [Related]
18. Opiate receptor mediated regulation of the immune response in vivo.
Weber RJ; Ikejiri B; Rice KC; Pert A; Hagan AA
NIDA Res Monogr; 1987; 76():341-8. PubMed ID: 2830526
[No Abstract] [Full Text] [Related]
19. The effect of adult exposure to diethylstilbestrol in the mouse: alterations in immunological functions.
Luster MI; Boorman GA; Dean JH; Luebke RW; Lawson LD
J Reticuloendothel Soc; 1980 Dec; 28(6):561-9. PubMed ID: 6450833
[No Abstract] [Full Text] [Related]
20. Continuous versus intermittent oral therapy with estramustine phosphate (Estracyt).
Vahlensieck W; Wegner G
Scand J Urol Nephrol Suppl; 1980; 55():147-9. PubMed ID: 6938018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
